Healthstream (HSTM) Cash from Financing Activities (2010 - 2026)

Healthstream (HSTM) has 17 years of Cash from Financing Activities data on file, last reported at -$8.3 million in Q1 2026.

• On a quarterly basis, Cash from Financing Activities fell 313.96% year-over-year to -$8.3 million in Q1 2026; TTM through Mar 2026 was -$42.6 million, a 782.63% decrease from a year earlier, with the FY2025 full-year figure at -$36.3 million, down 703.08% from the prior year.
• Cash from Financing Activities for Q1 2026 stood at -$8.3 million, down from -$7.2 million in the prior quarter.
• Over the last five years, Cash from Financing Activities for HSTM reached as high as -$20000.0 in Q3 2022 and fell as low as -$20.2 million in Q1 2022.
• Historically, Cash from Financing Activities has averaged -$5.1 million across 5 years, with a median of -$2.0 million in 2025.
• Across the five-year window, Cash from Financing Activities surged 99.18% in 2022 and sank 17502.13% in 2023, its largest moves.
• Year by year, Cash from Financing Activities stood at -$47000.0 in 2022, then sank by 17502.13% to -$8.3 million in 2023, then soared by 87.51% to -$1.0 million in 2024, then slumped by 601.26% to -$7.2 million in 2025, then dropped by 15.03% to -$8.3 million in 2026.
• Per Business Quant data, the three most recent Cash from Financing Activities figures were -$8.3 million in Q1 2026, -$7.2 million in Q4 2025, and -$7.9 million in Q3 2025.